Terms: = Prostate cancer AND JAK1, ENSG00000162434, P23458, JTK3, JAK1B, JAK1A, 3716
47 results:
1. Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the jak1/STAT4 pathway.
Cheng B; Li L; Luo T; Wang Q; Luo Y; Bai S; Li K; Lai Y; Huang H
J Exp Clin Cancer Res; 2024 Mar; 43(1):67. PubMed ID: 38429845
[TBL] [Abstract] [Full Text] [Related]
2. Dieckol prevents prostate cancer cell proliferation by transcriptionally attenuating JAK/STAT3 signaling pathway.
Karuppaiya V; Annamalai A; Krishnamurthy S; Soundarapandian K
Environ Toxicol; 2024 Mar; 39(3):1187-1196. PubMed ID: 37886886
[TBL] [Abstract] [Full Text] [Related]
3. Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients.
Lang B; Cao C; Zhao X; Wang Y; Cao Y; Zhou X; Zhao T; Wang Y; Liu T; Liang W; Hu Z; Tian X; Zhang J; Yan Y
Eur J Med Res; 2023 Jul; 28(1):239. PubMed ID: 37461056
[TBL] [Abstract] [Full Text] [Related]
4. CircMTO1: A circular RNA with roles in the carcinogenesis.
Ghafouri-Fard S; Khoshbakht T; Bahranian A; Taheri M; Hallajnejad M
Biomed Pharmacother; 2021 Oct; 142():112025. PubMed ID: 34392090
[TBL] [Abstract] [Full Text] [Related]
5. Inhibition of Janus Kinase 1 synergizes docetaxel sensitivity in prostate cancer cells.
Nalairndran G; Chung I; Abdul Razack AH; Chung FF; Hii LW; Lim WM; Looi CK; Mai CW; Leong CO
J Cell Mol Med; 2021 Sep; 25(17):8187-8200. PubMed ID: 34322995
[TBL] [Abstract] [Full Text] [Related]
6. Blockage of the JAK/STAT3 signaling pathway in multiple myeloma by leelamine.
Jung YY; Um JY; Nasif O; Alharbi SA; Sethi G; Ahn KS
Phytomedicine; 2021 Jul; 87():153574. PubMed ID: 34006448
[TBL] [Abstract] [Full Text] [Related]
7. miR‑583 inhibits the proliferation and invasion of prostate cancer cells by targeting jak1.
Li Z; Chen J
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495837
[TBL] [Abstract] [Full Text] [Related]
8. LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway.
Jung YY; Ko JH; Um JY; Chinnathambi A; Alharbi SA; Sethi G; Ahn KS
J Cell Physiol; 2021 Jul; 236(7):5253-5264. PubMed ID: 33368314
[TBL] [Abstract] [Full Text] [Related]
9. Novel Long Non-coding RNA lncAMPC Promotes Metastasis and Immunosuppression in prostate cancer by Stimulating LIF/LIFR Expression.
Zhang W; Shi X; Chen R; Zhu Y; Peng S; Chang Y; Nian X; Xiao G; Fang Z; Li Y; Cao Z; Zhao L; Liu G; Sun Y; Ren S
Mol Ther; 2020 Nov; 28(11):2473-2487. PubMed ID: 32592689
[TBL] [Abstract] [Full Text] [Related]
10. An Emerging Landscape for Canonical and Actionable Molecular Alterations in Primary and Metastatic prostate cancer.
Dawson NA; Zibelman M; Lindsay T; Feldman RA; Saul M; Gatalica Z; Korn WM; Heath EI
Mol Cancer Ther; 2020 Jun; 19(6):1373-1382. PubMed ID: 32220973
[TBL] [Abstract] [Full Text] [Related]
11. Attenuation of STAT3 Signaling Cascade by Daidzin Can Enhance the Apoptotic Potential of Bortezomib against Multiple Myeloma.
Yang MH; Jung SH; Chinnathambi A; Alahmadi TA; Alharbi SA; Sethi G; Ahn KS
Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31878046
[TBL] [Abstract] [Full Text] [Related]
12. Combined inhibition of jak1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia.
Xu LJ; Ma Q; Zhu J; Li J; Xue BX; Gao J; Sun CY; Zang YC; Zhou YB; Yang DR; Shan YX
Mol Med Rep; 2018 Jun; 17(6):8111-8120. PubMed ID: 29693186
[TBL] [Abstract] [Full Text] [Related]
13. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
Pritchard AL; Johansson PA; Nathan V; Howlie M; Symmons J; Palmer JM; Hayward NK
PLoS One; 2018; 13(4):e0194098. PubMed ID: 29641532
[TBL] [Abstract] [Full Text] [Related]
14. Interleukin-6 and Interferon-α Signaling
Danziger O; Pupko T; Bacharach E; Ehrlich M
Front Immunol; 2018; 9():94. PubMed ID: 29441069
[TBL] [Abstract] [Full Text] [Related]
15. Loss of function jak1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion.
Albacker LA; Wu J; Smith P; Warmuth M; Stephens PJ; Zhu P; Yu L; Chmielecki J
PLoS One; 2017; 12(11):e0176181. PubMed ID: 29121062
[TBL] [Abstract] [Full Text] [Related]
16. Tofacitinib and analogs as inhibitors of the histone kinase PRK1 (PKN1).
Ostrovskyi D; Rumpf T; Eib J; Lumbroso A; Slynko I; Klaeger S; Heinzlmeir S; Forster M; Gehringer M; Pfaffenrot E; Bauer SM; Schmidtkunz K; Wenzler S; Metzger E; Kuster B; Laufer S; Schüle R; Sippl W; Breit B; Jung M
Future Med Chem; 2016 Sep; 8(13):1537-51. PubMed ID: 27572962
[TBL] [Abstract] [Full Text] [Related]
17. Capsazepine inhibits JAK/STAT3 signaling, tumor growth, and cell survival in prostate cancer.
Lee JH; Kim C; Baek SH; Ko JH; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS
Oncotarget; 2017 Mar; 8(11):17700-17711. PubMed ID: 27458171
[TBL] [Abstract] [Full Text] [Related]
18. Combined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infection.
Danziger O; Shai B; Sabo Y; Bacharach E; Ehrlich M
Oncotarget; 2016 Aug; 7(32):52115-52134. PubMed ID: 27366948
[TBL] [Abstract] [Full Text] [Related]
19. SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in prostate cancer Cells.
Handle F; Erb HH; Luef B; Hoefer J; Dietrich D; Parson W; Kristiansen G; Santer FR; Culig Z
Mol Cancer Res; 2016 Jun; 14(6):574-85. PubMed ID: 27053681
[TBL] [Abstract] [Full Text] [Related]
20. N-3 polyunsaturated fatty acids inhibit IFN-γ-induced IL-18 binding protein production by prostate cancer cells.
Wang X; Breeze A; Kulka M
Cancer Immunol Immunother; 2015 Feb; 64(2):249-58. PubMed ID: 25351720
[TBL] [Abstract] [Full Text] [Related]
[Next]